Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Turnera diffusa leaf, commonly known as Damiana, is the dried or fresh foliage of Turnera diffusa, a wild shrub native to Mexico, Central America, and the West Indies. Traditionally used in herbal medicine and as a dietary supplement, Damiana has been employed for its purported aphrodisiac effects and to address conditions such as headache, depression, nervous stomach, constipation, bedwetting, menopausal symptoms, premenstrual syndrome (PMS), anxiety, diabetes management support and weight loss. The plant contains various bioactive compounds including flavonoids (such as apigenin), arbutin, tannins and cyanogenic glycosides. While some of these constituents may have antioxidant or anti-inflammatory properties and could potentially improve stomach health or reduce ulcers by unknown mechanisms of action on gastrointestinal tissues or neurotransmitter systems[1][2][7], there is insufficient clinical evidence supporting any specific therapeutic benefit. Turnera diffusa is not an approved pharmaceutical drug but is available in over-the-counter products marketed primarily as herbal supplements[3][5]. No standardization exists for preparations; safety data are limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on turnera diffusa leaf.